| scholarly article | Q13442814 |
| P50 | author | Gianfranco Ferraccioli | Q41067658 |
| P2093 | author name string | Annie Chen | |
| Roy Fleischmann | |||
| William Rigby | |||
| Gillian Armstrong | |||
| Angelika Jahreis | |||
| Siegfried Wassenberg | |||
| Maria Greenwald | |||
| Sarika Ogale | |||
| Christopher Mela | |||
| Laura Burke | |||
| Beatriz Zazueta-Montiel | |||
| P2860 | cites work | The Stanford Health Assessment Questionnaire: dimensions and practical applications | Q24806173 |
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Incomplete quality of life data in randomized trials: missing items. | Q32067201 | ||
| Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components | Q33256077 | ||
| Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. | Q33648354 | ||
| The links between joint damage and disability in rheumatoid arthritis | Q33867923 | ||
| Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis | Q33910329 | ||
| Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab' | Q34125254 | ||
| Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis | Q34327451 | ||
| Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis | Q34657863 | ||
| Appropriate and effective management of rheumatoid arthritis | Q35554231 | ||
| Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment | Q35638735 | ||
| Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial | Q36946654 | ||
| A critical review of visual analogue scales in the measurement of clinical phenomena | Q37942859 | ||
| Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial | Q38498967 | ||
| Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy | Q39319086 | ||
| An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline | Q41671791 | ||
| Confidence intervals for the number needed to treat | Q42759158 | ||
| Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks | Q44774931 | ||
| American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis | Q47643186 | ||
| Patient- versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy | Q48008853 | ||
| Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial. | Q51764647 | ||
| Fatigue in rheumatoid arthritis reflects pain, not disease activity. | Q51921781 | ||
| P433 | issue | 5 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| rituximab | Q412323 | ||
| quality of life | Q13100823 | ||
| P304 | page(s) | 711-720 | |
| P577 | publication date | 2011-05-01 | |
| P1433 | published in | Arthritis Care and Research | Q15754720 |
| P1476 | title | Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate | |
| P478 | volume | 63 |
| Q35080662 | A community-based validation study of the short-form 36 version 2 Philippines (Tagalog) in two cities in the Philippines. |
| Q26471538 | Biologic interventions for fatigue in rheumatoid arthritis |
| Q36195284 | Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA). |
| Q30234528 | Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. |
| Q30235341 | Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. |
| Q67396259 | Comparative Effectiveness of Combining MTX with Biologic Drug Therapy Versus Either MTX or Biologics Alone for Early Rheumatoid Arthritis in Adults: a Systematic Review and Network Meta-analysis. |
| Q47778526 | Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life. |
| Q36219954 | Efficacy and safety of rituximab therapy for systemic lupus erythematosus: a systematic review and meta-analysis |
| Q90264892 | Fatigue in early, intensively treated and tight-controlled rheumatoid arthritis patients is frequent and persistent: a prospective study |
| Q38129036 | Impact of biologic therapy on functional status in patients with rheumatoid arthritis--a meta-analysis. |
| Q34975404 | Low- versus high-dose rituximab for rheumatoid arthritis: a systematic review and meta-analysis |
| Q93052257 | Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab |
| Q28710161 | Regional and temporal variation in the treatment of rheumatoid arthritis across the UK: a descriptive register-based cohort study |
| Q88780685 | Rituximab Is Ineffective for Treatment of Fatigue in Primary Biliary Cholangitis: A Phase 2 Randomized Controlled Trial |
| Q38233120 | Rituximab for rheumatoid arthrits treatment: a systematic review. |
| Q35751550 | Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE. |
| Q58800873 | Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland |
| Q52887079 | [Systematic literature research for S1 guidelines on sequential medical treatment of rheumatoid arthritis]. |
Search more.